Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC NASDAQ:BRTX NASDAQ:MGRX NASDAQ:NIVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$3.75-5.5%$3.71$2.01▼$15.60$7.13M5.08503,628 shs96,482 shsBRTXBiorestorative Therapies$1.54-3.8%$1.69$1.21▼$2.55$12.01M75.28145,128 shs134,123 shsMGRXMangoceuticals$1.47-3.3%$1.78$1.32▼$7.66$7.86M2.4218,367 shs48,976 shsNIVFNewGenIvf Group$0.59-7.3%$1.89$0.58▼$656.00$2.74M-0.031.05 million shs594,551 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-5.54%-41.31%+35.87%+40.45%-29.30%BRTXBiorestorative Therapies-3.76%-10.47%-8.34%-10.97%-13.00%MGRXMangoceuticals-3.29%-4.55%-27.59%-30.00%-98.31%NIVFNewGenIvf Group-7.30%-10.95%-65.42%-83.32%-99.70%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBGLCBioNexus Gene Lab1.2665 of 5 stars0.05.00.00.03.30.00.6BRTXBiorestorative Therapies3.783 of 5 stars3.55.00.00.03.33.30.6MGRXMangoceuticals0.6374 of 5 stars0.03.00.00.01.41.70.6NIVFNewGenIvf GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 0.00N/AN/AN/ABRTXBiorestorative Therapies 3.00Buy$18.001,068.91% UpsideMGRXMangoceuticals 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$9.51M0.71N/AN/A$4.63 per share0.81BRTXBiorestorative Therapies$400K28.87N/AN/A$1.23 per share1.25MGRXMangoceuticals$620K12.26N/AN/A$4.30 per share0.34NIVFNewGenIvf Group$5.43M0.47N/AN/A($29.20) per share-0.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-22.85%-24.18%-20.14%N/ABRTXBiorestorative Therapies-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)MGRXMangoceuticals-$8.71M-$4.64N/A∞N/A-2,191.76%-72.81%-66.58%8/13/2025 (Estimated)NIVFNewGenIvf Group-$520KN/A0.00∞N/AN/AN/AN/AN/ALatest NIVF, BRTX, BGLC, and MGRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025BRTXBiorestorative Therapies-$0.41N/AN/AN/A$0.34 millionN/A5/15/2025Q1 2025BGLCBioNexus Gene LabN/A-$0.03N/A-$0.03N/AN/A5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million5/14/2025Q1 2025BRTXBiorestorative Therapies-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/ABRTXBiorestorative TherapiesN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A4.193.44BRTXBiorestorative TherapiesN/A2.242.24MGRXMangoceuticalsN/A0.120.12NIVFNewGenIvf GroupN/A1.171.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%BRTXBiorestorative Therapies69.38%MGRXMangoceuticals56.72%NIVFNewGenIvf Group66.24%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.70%BRTXBiorestorative Therapies25.50%MGRXMangoceuticals16.00%NIVFNewGenIvf Group31.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableBRTXBiorestorative Therapies77.50 million5.59 millionNot OptionableMGRXMangoceuticals35.17 million4.34 millionNot OptionableNIVFNewGenIvf GroupN/A4.32 million2.95 millionN/ANIVF, BRTX, BGLC, and MGRX HeadlinesRecent News About These CompaniesNewGenIvf Group approves reverse stock split and increases authorized sharesJuly 9, 2025 | uk.investing.comNewGenIvf explores $400 million real estate tokenization in UAEJuly 3, 2025 | uk.investing.comNewGenIvf Group Limited (NIVF) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comNewGen Subsidiary Secures Strategic UAE Land and Begins Exploration of Potential Real World Asset Tokenization InitiativeJuly 1, 2025 | tmcnet.comNewGenIvf Group’s Subsidiary Secures UAE Land for Blockchain InitiativeJuly 1, 2025 | tipranks.comNewGenIvf Group Limited Secures Strategic Land Plot in UAE for Digital Asset Tokenization InitiativeJuly 1, 2025 | quiverquant.comQNewGenIvf Group Ltd Ordinary Shares - Class A - MorningstarJune 28, 2025 | morningstar.comMNewGenIvf Group Expands Share Base with Strategic IssuancesJune 20, 2025 | tipranks.comNewGenIvf Group to Present Digital Asset Updates at Emerging Growth ConferenceJune 17, 2025 | tipranks.comNewGen announces $45 million strategic investment in UAE real estate marketJune 12, 2025 | kalkinemedia.comKNewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate MarketJune 12, 2025 | globenewswire.comBRIEF-NewGenIvf Group Files For Offering Of 22.02 Million Class A Ordinary Shares By Selling StockholdersJune 5, 2025 | sg.finance.yahoo.comNewGenIvf Group Announces Planned $30M Strategic Investment in Solana StakingJune 4, 2025 | uk.investing.comNewGenIvf Plans To Invest $30 Mln In SolanaJune 4, 2025 | nasdaq.comNewGenIvf Group Secures $3.2 Million in Debt FinancingJune 4, 2025 | tipranks.comNewGenIvf Group Ltd.June 2, 2025 | wsj.comNewGen Doubles Down on Solana with $30 Million SOL Staking StrategyJune 2, 2025 | coingape.comCNewGenIvf Group Limited Announces $30 Million Investment in Solana to Expand Digital Asset StrategyJune 2, 2025 | quiverquant.comQNewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset StakingJune 2, 2025 | globenewswire.comNIVF NewGenIvf Group LimitedMay 30, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNIVF, BRTX, BGLC, and MGRX Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$3.75 -0.22 (-5.54%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$3.82 +0.08 (+2.00%) As of 07/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Biorestorative Therapies NASDAQ:BRTX$1.54 -0.06 (-3.76%) Closing price 07/15/2025 03:54 PM EasternExtended Trading$1.54 0.00 (-0.32%) As of 07/15/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Mangoceuticals NASDAQ:MGRX$1.47 -0.05 (-3.29%) Closing price 07/15/2025 03:59 PM EasternExtended Trading$1.49 +0.02 (+1.36%) As of 07/15/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.NewGenIvf Group NASDAQ:NIVF$0.59 -0.05 (-7.30%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$0.59 +0.00 (+0.03%) As of 07/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Fastenal Surges After Earnings Beat, Tariff Risks Loom Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
